The CHA
2DS
2-VASc score (congestive heart failure, hypertension, age 75 years or older, diabetes, prior stroke/transient ischemic attack–vascular disease, age 65-74 years, sex category) is widely used in Europe and the United States for thromboembolic risk stratification in patients with nonvalvular atrial fibrillation (NVAF),
1,2 whereas CHADS
2 (congestive heart failure, hypertension, aged 75 years or older, diabetes, prior stroke/transient ischemic attack) score is used in Japan.
3 In a previous study,
4 we showed that both scores are useful for risk stratification in Japanese NVAF patients. But all CHADS
2 score factors may not necessarily represent risks for thromboembolism. Our previous pooled data of the J-RHYTHM (Japanese Rhythm Management Trial for Atrial Fibrillation) Registry, Fushimi AF Registry, and Shinken Database showed that, for patients without oral anticoagulants (OAC), age 75 years or older, hypertension, and previous stroke or transient ischemic attack were independent risk factors associated with ischemic stroke, but diabetes or heart failure were not.
5 The pooled data also showed that the annual ischemic stroke rate was 0.9%, 1.5%, and 2.7% in individuals with a CHADS
2 score of 1, 2, and 3, respectively, which was lower than those shown in the original data.
5,6 These findings suggest some differences in risk factors associated with thromboembolism by race and region.